112 related articles for article (PubMed ID: 19155082)
1. The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice.
Björnsson E; Davidsdottir L
J Hepatol; 2009 Mar; 50(3):511-7. PubMed ID: 19155082
[TBL] [Abstract][Full Text] [Related]
2. Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States?
Vuppalanchi R; Liangpunsakul S; Chalasani N
Am J Gastroenterol; 2007 Mar; 102(3):558-62; quiz 693. PubMed ID: 17156142
[TBL] [Abstract][Full Text] [Related]
3. Mortality and causes of death in patients with "lupoid hepatitis." A long-term follow-up study in Denmark.
Poulsen LO; Thulstrup AM; Mellemkjaer L; Vilstrup H; Sørensen HT
Dan Med Bull; 2002 Aug; 49(3):263-5. PubMed ID: 12238290
[TBL] [Abstract][Full Text] [Related]
4. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry.
Andrade RJ; Lucena MI; Kaplowitz N; García-Muņoz B; Borraz Y; Pachkoria K; García-Cortés M; Fernández MC; Pelaez G; Rodrigo L; Durán JA; Costa J; Planas R; Barriocanal A; Guarner C; Romero-Gomez M; Muņoz-Yagüe T; Salmerón J; Hidalgo R
Hepatology; 2006 Dec; 44(6):1581-8. PubMed ID: 17133470
[TBL] [Abstract][Full Text] [Related]
5. Drug associated hepatic reactions in New Zealand: 21 years experience.
Pillans PI
N Z Med J; 1996 Aug; 109(1028):315-9. PubMed ID: 8816722
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced liver injury: a cohort study on patients referred to the Danish transplant center over a five year period.
Baekdal M; Ytting H; Skalshøi Kjær M
Scand J Gastroenterol; 2017 Apr; 52(4):450-454. PubMed ID: 27973926
[TBL] [Abstract][Full Text] [Related]
7. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma.
Romeo R; Del Ninno E; Rumi M; Russo A; Sangiovanni A; de Franchis R; Ronchi G; Colombo M
Gastroenterology; 2009 May; 136(5):1629-38. PubMed ID: 19208358
[TBL] [Abstract][Full Text] [Related]
8. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome of hepatitis C infection after liver transplantation.
Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.
Hui JM; Kench JG; Chitturi S; Sud A; Farrell GC; Byth K; Hall P; Khan M; George J
Hepatology; 2003 Aug; 38(2):420-7. PubMed ID: 12883486
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.
Arase Y; Ikeda K; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Hosaka T; Sezaki H; Kobayashi M; Kumada H
Am J Med; 2006 Jan; 119(1):71.e9-16. PubMed ID: 16431195
[TBL] [Abstract][Full Text] [Related]
12. Halothane hepatitis in a South African population--frequency and the influence of gender and ethnicity.
Voigt MD; Workman B; Lombard C; Kirsch RE
S Afr Med J; 1997 Jul; 87(7):882-5. PubMed ID: 9259724
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up among Danish transfusion recipients identified in the national hepatitis C lookback.
Just SA; Grau K; Georgsen J; Weis N; Cowan S; Groenbaek K; Krarup H; Christensen PB;
Transfusion; 2012 Mar; 52(3):582-8. PubMed ID: 21883266
[TBL] [Abstract][Full Text] [Related]
14. Favorable outcomes of autoimmune hepatitis in a community clinic setting.
Seo S; Toutounjian R; Conrad A; Blatt L; Tong MJ
J Gastroenterol Hepatol; 2008 Sep; 23(9):1410-4. PubMed ID: 18373564
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications.
Pradat P; Tillmann HL; Sauleda S; Braconier JH; Saracco G; Thursz M; Goldin R; Winkler R; Alberti A; Esteban JI; Hadziyannis S; Rizzetto M; Thomas H; Manns MP; Trepo C;
J Viral Hepat; 2007 Aug; 14(8):556-63. PubMed ID: 17650289
[TBL] [Abstract][Full Text] [Related]
16. The natural history of chronic hepatitis B: a retrospective study.
Wu GC; Zhou WP; Zhao YR; Guo SH; Wang ZY; Zou SB; Zhang QH; Ren H; Huang AL; Zhang DF
Hepatobiliary Pancreat Dis Int; 2003 Nov; 2(4):566-70. PubMed ID: 14627521
[TBL] [Abstract][Full Text] [Related]
17. Recurrent drug-induced liver injury (DILI) with different drugs in the Spanish Registry: the dilemma of the relationship to autoimmune hepatitis.
Lucena MI; Kaplowitz N; Hallal H; Castiella A; García-Bengoechea M; Otazua P; Berenguer M; Fernandez MC; Planas R; Andrade RJ
J Hepatol; 2011 Oct; 55(4):820-7. PubMed ID: 21338638
[TBL] [Abstract][Full Text] [Related]
18. Short and long-term effects of bacterial translocation due to obstructive jaundice on liver damage.
Sakrak O; Akpinar M; Bedirli A; Akyurek N; Aritas Y
Hepatogastroenterology; 2003; 50(53):1542-6. PubMed ID: 14571782
[TBL] [Abstract][Full Text] [Related]
19. Natural history of compensated viral B and D cirrhosis.
Gheorghe L; Iacob S; Simionov I; Vadan R; Gheorghe C; Iacob R; Parvulescu I; Constantinescu I
Rom J Gastroenterol; 2005 Dec; 14(4):329-35. PubMed ID: 16400347
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic therapy: a major cause of drug-induced jaundice in southwest England.
Hussaini SH; O'Brien CS; Despott EJ; Dalton HR
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):15-20. PubMed ID: 17206072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
